| bioMérieux to showcase Innovation@Work at the International Association for Food Protection Annual Meeting
Introducing innovative industry-first solutions with interactive presentations
St. Louis, MO (August 2, 2006) — bioMérieux, Inc., a leading industrial microbiology and diagnostics company, will introduce its latest product for quality testing, TEMPO®, and will host a number of educational events at the International Association for Food Protection (IAFP) 93rd Annual Meeting in Calgary, Alberta, Canada. bioMérieux will address topics having an immediate impact on the food quality industry during the “Innovation@Work for Quality Indicator Testing” Symposium. Additionally, bioMérieux will showcase the interactive forums for food safety and protection, as well as a roundtable discussion with industry leaders.
The Quality Indicator Testing Symposium will begin with a keynote address by Dr. Bala Swaminathan of the Centers for Disease Control and Prevention, focusing on a 20-year journey of progress in food safety. Swaminathan will discuss existing problems from a diagnostic perspective, along with key pathogens and quality indicator organisms and their role in food safety and security. Following the keynote address, bioMérieux will sponsor a roundtable discussion with key opinion leaders who will share their scientific experiences with TEMPO, the first automated quality indicator testing system. Attended by companies including Nestle USA and Tyson Foods, the discussion will provide firsthand reports on workflow, performance data, and laboratory implementation of the new system.
In addition to the roundtable discussion, IAFP attendees will be able to experience TEMPO at bioMérieux’s booth. “We are proud to unveil an industry-first with the TEMPO quality indicator testing system,” said Eric Bouvier, bioMérieux president, North America. “TEMPO provides a new tool, unlike any other, for the enumeration of quality indicator organisms in food and environmental samples. This revolutionary system delivers an innovative solution for complete sample result traceability and increased time management, while controlling costs in a food facility.
Also on display at IAFP will be bioMérieux’s “Brain Food” education series, an interactive food safety and protection initiative. Brain Food consists of a series of live presentations designed to help companies make moreAlso on display at IAFP will be bioMérieux’s “Brain Food” education series, an interactive food safety and protection initiative. Brain Food consists of a series of live presentations designed to help companies make more informed decisions regarding food protection and safety. The live web-based educational series explores the entire food production cycle from farm to family on an online meeting site that allows individuals to communicate through conferences, webinars and webcasts.
As part of the innovation@work initiative, bioMérieux’s Innovation in Motion 93-city tour will make a stop in Calgary, Canada for IAFP. The show attendees will also have the opportunity to experience the tour bus, which includes a presentation theater and working mobile laboratory, with demonstrations of the BacT/ALERT® 3D bacterial identification system, mini VIDAS®, VITEK® 2 Compact, culture media, and TEMPO. The bus is currently making its way across the country on an eight-month tour to provide laboratory technicians, microbiologists and physicians, as well as quality assurance and product management across the country with innovative diagnostic technologies. The tour bus, which hit the streets in June this year, will be located on Stephen Avenue, a pedestrian walkway located just in front of the Calgary Telus Convention Centre.
Visit bioMérieux at the IAFP 93rd Annual Meeting, August 13-16, 2006, at booth #701. The meeting will take place at the Calgary Telus Convention Centre in Calgary, Alberta, Canada.
About bioMérieux, Inc.
bioMérieux is a leading international diagnostics group that specializes in the field of in vitro diagnostics for clinical and industrial applications. bioMérieux designs, develops, manufactures and markets systems (i.e. reagents, instruments and software) used in:
Clinical applications:
the diagnosis of infectious diseases such as hepatitis, HIV, tuberculosis and respiratory illnesses, as well as pathologies such as cardiovascular diseases and cancer, based on the analysis of biological samples (such as blood, saliva or urine); and
Industrial applications: the microbiological analysis of food, environments (such as water and air), surfaces and pharmaceutical and cosmetic products, based on the analysis of product or environmental samples.
In 2005, bioMérieux sales reached 994 million euros. The company is present in more than 130 countries through 35 subsidiaries and a large network of distributors, which positions the company well to benefit from the growth potential of the in vitro diagnostics market. Some important drivers that underpin this growth are aging populations and age-related illness, illnesses related to life-style and eating habits, emerging new pathogens, the development of antibiotic-resistant bacteria, the fight against bio-terrorism, and the recognition of the importance of the quality of food products. bioMérieux is listed on the Eurolist of Euronext, Paris (FR0010096479 – BIM). Other information can be found at www.biomerieux-usa.com
Return to bioMérieux News |
